Please login to the form below

Not currently logged in
Email:
Password:

Oliceridine

This page shows the latest Oliceridine news and features for those working in and with pharma, biotech and healthcare.

Trevena gets second go at FDA approval for pain drug

Trevena gets second go at FDA approval for pain drug

FDA sets review completion date of 7 August 2020. US biotech Trevena has resubmitted its lead drug oliceridine for moderate-to-severe pain in the US, 18 months after it was ... the FDA’s review of oliceridine and the first quarter of next year.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...